<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Tue, 12 May 2026 09:27:56 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/vtvt/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Top Gainers for 2-10-20: $ADVM $TCO $VTVT]]></title><description><![CDATA[$ADVM - Adverum Biotechnologies Reports New Interim Data from Cohorts 1 and 2 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at Angiogenesis, Exudation, and Degeneration 2020:]]></description><link>http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-2-10-20-usdadvm-usdtco-usdvtvt</link><guid isPermaLink="true">http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-2-10-20-usdadvm-usdtco-usdvtvt</guid><category><![CDATA[topgainers]]></category><dc:creator><![CDATA[jktrades]]></dc:creator><pubDate>Mon, 10 Feb 2020 18:17:09 GMT</pubDate><enclosure url="https://images.ecency.com/p/TZjG7hXReeVoAvXt2X6pMxYAb3q65xMju8wryWxKrsghkLRDzSUcQYomzXnbn3i1Urvo427LyBfZv3jtbqC1Y78dTiTxtCssuNXoPnjmgPjssjoraxqLFnxxZbNao5ny7F8FhZ9pR5UCf8?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>